NXPL
NextPlat Corp
Company overview
- Market capitalization
- $24.96M
- Employees
- 121
- Latest publication
- 2026-09-29
About NextPlat Corp
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, Asia and Pacific, and Africa. It operates through two segments, e-Commerce Operations and Healthcare Operations. The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, medication adherence packaging, contracted pharmacy services, health practice risk management, disease testing, contracted pharmacy, and vaccinations services, as well as supplies prescription medications. It also operates e-commerce websites, as well as third-party e-commerce storefronts that provide mobile satellite services solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and internet of things connectivity services; voice, data communications, internet of things (IoT), and machine-to-machine services; tracking and monitoring services; satellite communications products; GPS enabled emergency locator distress beacons; satellite tracking devices used to monitor the location, movements, and history of anything that moves; and GTCTrack, a subscription-based mapping and tracking portal that provides a universal and hardware-agnostic, cloud-based data visualization and management platform. In addition, the company provides value-added services, such as prior authorization assistance, same-day home-medication delivery, on-site provider consultation services, primary care reporting and analytics, and customized packaging solutions. Further, it offers satellite phones, tracking devices, broadband terminals, messaging plans, and connectivity services. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp was founded in 2008 and is headquartered in Hallandale Beach, Florida.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11,881,000USD | 9,855,000USD | 12,805,000USD | 13,752,000USD | 13,240,000USD | 14,525,000USD | 15,634,000USD | 15,367,000USD |
| Cost Of Revenue | 7,187,000USD | 8,952,000USD | 10,975,000USD | 11,022,000USD | 10,357,000USD | 11,062,000USD | 13,541,000USD | 11,847,000USD |
| Gross Profit | 4,694,000USD | 903,000USD | 1,830,000USD | 2,730,000USD | 2,883,000USD | 3,463,000USD | 2,093,000USD | 3,520,000USD |
| Selling General Administrative | 2,445,000USD | 4,425,000USD | 5,161,000USD | 4,564,000USD | 4,537,000USD | 4,752,000USD | 4,769,000USD | 7,312,000USD |
| Total Operating Expenses | 4,821,000USD | 2,005,999USD | 5,277,000USD | 4,719,000USD | 4,712,000USD | 4,948,000USD | 4,980,000USD | 11,519,000USD |
| Net Income | -144,000USD | -1,118,000USD | -6,395,000USD | -2,185,000USD | -1,789,000USD | -1,343,000USD | -3,017,000USD | -4,216,000USD |
| Unclassified Operating Expenses | — | -2,419,001USD | — | — | — | — | — | — |
| Operating Income | — | -1,103,000USD | -3,447,000USD | -1,989,000USD | -1,829,000USD | -1,485,000USD | -2,887,000USD | -7,999,000USD |
| Income Before Tax | — | -1,132,000USD | -5,160,000USD | -2,211,000USD | -1,758,000USD | -1,334,000USD | -3,038,000USD | -7,619,000USD |
| Income Tax Expense | — | -14,000USD | 1,235,000USD | -26,000USD | 31,000USD | 9,000USD | -21,000USD | 45,000USD |
| Tax Provision | — | 0USD | -14,000USD | -26,000USD | 31,000USD | 9,000USD | -21,000USD | 45,000USD |
| Net Income From Continuing Ops | — | -1,132,000USD | -5,146,000USD | -2,185,000USD | -1,789,000USD | -1,343,000USD | -3,017,000USD | -7,664,000USD |
| Ebit | — | -1,103,000USD | -5,143,000USD | -2,197,000USD | -1,743,000USD | -1,316,000USD | -3,019,000USD | -7,597,000USD |
| Ebitda | — | -1,013,000USD | -5,412,000USD | -1,946,000USD | -1,480,000USD | -1,021,000USD | -2,725,000USD | -7,119,000USD |
| Depreciation And Amortization | — | 90,000USD | -269,000USD | 251,000USD | 263,000USD | 295,000USD | 294,000USD | 478,000USD |
| Reconciled Depreciation | — | 149,000USD | 229,000USD | 251,000USD | 263,000USD | 295,000USD | 294,000USD | 474,000USD |
| Total Other Income Expense Net | — | -29,000USD | -1,713,000USD | -222,000USD | 71,000USD | 151,000USD | -151,000USD | 380,000USD |
| Minority Interest | — | 14,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 3,448,000USD |
| Interest Income | — | — | 63,000USD | 88,000USD | 99,000USD | 108,000USD | 135,000USD | 183,000USD |
| Interest Expense | — | — | 17,000USD | 14,000USD | 15,000USD | 18,000USD | 19,000USD | 22,000USD |
| Net Interest Income | — | — | 46,000USD | 74,000USD | 84,000USD | 90,000USD | 116,000USD | 161,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 5,168,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 54,322,000USD | 65,483,000USD | 37,756,000USD | 11,710,000USD | 7,739,910USD | 5,689,796USD | 5,869,558USD | 5,726,572USD |
| Cost Of Revenue | 43,416,000USD | 49,254,000USD | 26,445,000USD | 9,221,000USD | 5,880,187USD | 4,464,476USD | 4,646,180USD | 4,691,748USD |
| Gross Profit | 10,906,000USD | 16,229,000USD | 11,311,000USD | 2,489,000USD | 1,859,723USD | 1,225,320USD | 1,223,378USD | 1,034,824USD |
| Selling General Administrative | 19,014,000USD | 4,401,000USD | 18,534,000USD | 9,202,000USD | 8,164,954USD | 2,964,274USD | 2,059,378USD | 249,675USD |
| Total Operating Expenses | 19,656,000USD | 39,853,000USD | 34,539,000USD | 9,692,000USD | 8,482,056USD | 3,259,200USD | 2,334,706USD | 2,164,460USD |
| Operating Income | -8,750,000USD | -23,624,000USD | -23,228,000USD | -7,203,000USD | -6,622,333USD | -2,033,880USD | -1,111,328USD | -1,129,636USD |
| Interest Income | 358,000USD | 731,000USD | 399,938USD | 20,814USD | 6,876USD | 115USD | 1,616USD | — |
| Interest Expense | 64,000USD | 81,000USD | 79,000USD | 24,000USD | 1,467,300USD | 1,022,024USD | 293,495USD | 110USD |
| Net Interest Income | 294,000USD | 650,000USD | 335,433USD | -3,683USD | -1,460,424USD | -1,021,909USD | -291,879USD | -110USD |
| Income Before Tax | -10,463,000USD | -23,054,000USD | -12,379,000USD | -9,074,000USD | -8,107,662USD | -2,763,375USD | -1,379,009USD | -1,186,172USD |
| Income Tax Expense | 1,249,000USD | 71,000USD | 28,000USD | 87,000USD | 1,467,300USD | 1,047,624USD | 747USD | 8,534USD |
| Tax Provision | 0USD | 71,000USD | 162,034USD | 87,000USD | 0USD | 2USD | 747USD | 8,534USD |
| Net Income | -11,712,000USD | -14,025,000USD | -3,778,000USD | -9,161,000USD | -8,107,662USD | -2,763,375USD | -1,379,756USD | -1,194,706USD |
| Net Income From Continuing Ops | -10,463,000USD | -23,125,000USD | -3,832,926USD | -9,160,589USD | -8,107,662USD | -2,763,375USD | -1,379,756USD | -1,194,706USD |
| Ebit | -10,399,000USD | -22,973,000USD | -22,212,000USD | -7,311,000USD | -6,640,362USD | -1,741,351USD | -1,085,514USD | -1,186,062USD |
| Ebitda | -9,859,000USD | -20,151,000USD | -19,685,000USD | -6,715,000USD | -6,290,297USD | -1,418,352USD | -800,634USD | -897,198USD |
| Depreciation And Amortization | 540,000USD | 2,822,000USD | 2,527,000USD | 596,000USD | 350,065USD | 322,999USD | 284,880USD | 288,864USD |
| Reconciled Depreciation | 1,038,000USD | 2,822,000USD | 1,578,083USD | 595,701USD | 350,065USD | 322,999USD | 284,880USD | 288,864USD |
| Total Other Income Expense Net | -1,713,000USD | 570,000USD | 10,849,000USD | -1,871,000USD | -1,485,329USD | -729,495USD | -267,681USD | -56,536USD |
| Minority Interest | 0USD | 9,100,000USD | 8,629,000USD | 0USD | — | — | — | — |
| Selling And Marketing Expenses | — | 3,459,000USD | 16,553,000USD | — | — | — | 761,237USD | 1,625,921USD |
| Unclassified Operating Expenses | — | 31,993,000USD | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -8,107,662USD | -2,763,375USD | -1,177,832USD | -1,194,706USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 28,672,000USD | 26,918,000USD | 27,465,000USD | 30,013,000USD | 31,033,000USD | 35,204,000USD | 36,478,000USD | 41,099,000USD |
| Cash And Equivalents | 11,940,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 25,146,000USD | 23,256,000USD | 24,156,000USD | 26,209,000USD | 26,855,000USD | 30,475,000USD | 31,480,000USD | 35,791,000USD |
| Total Liabilities | 12,187,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 10,982,000USD | 9,088,000USD | 9,126,000USD | 7,363,000USD | 6,208,000USD | 8,424,000USD | 8,210,000USD | 9,673,000USD |
| Total Stockholder Equity | 16,485,000USD | 16,474,000USD | 17,308,000USD | 21,432,000USD | 23,494,000USD | 25,337,000USD | 26,684,000USD | 22,463,000USD |
| Total Equity Including Noncontrolling Interest | 16,485,000USD | — | — | — | — | — | — | — |
| Net Receivables | 8,249,000USD | 7,226,000USD | 6,588,000USD | 6,411,000USD | 4,691,000USD | 7,830,000USD | 6,235,000USD | 8,585,000USD |
| Inventory | 4,058,000USD | 3,968,000USD | 3,396,000USD | 5,616,000USD | 5,215,000USD | 4,510,000USD | 4,881,000USD | 6,362,000USD |
| Property Plant Equipment Net | 2,390,000USD | 3,072,000USD | 2,694,000USD | 3,121,000USD | 3,462,000USD | 3,981,000USD | 4,224,000USD | 4,503,000USD |
| Goodwill | 156,000USD | — | — | — | — | — | — | — |
| Other Current Assets | — | 1,054,000USD | 463,000USD | 256,000USD | 314,000USD | 398,000USD | 404,000USD | 484,000USD |
| Total Liab | — | 10,344,000USD | 10,043,000USD | 8,467,000USD | 7,425,000USD | 9,753,000USD | 9,680,000USD | 11,306,000USD |
| Other Current Liab | — | 204,000USD | 2,535,000USD | 1,139,000USD | 578,000USD | 774,000USD | 682,000USD | 752,000USD |
| Common Stock | — | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 2,000USD |
| Capital Stock | — | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 2,000USD |
| Retained Earnings | — | -61,181,000USD | -60,063,000USD | -54,267,000USD | -52,082,000USD | -50,293,000USD | -48,950,000USD | -45,933,000USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 11,008,000USD | 13,709,000USD | 13,926,000USD | 16,635,000USD | 17,737,000USD | 19,960,000USD | 20,360,000USD |
| Cash And Short Term Investments | — | 11,008,000USD | 13,709,000USD | 13,926,000USD | 16,635,000USD | 17,737,000USD | 19,960,000USD | 20,360,000USD |
| Net Debt | — | -9,216,000USD | -12,218,000USD | -12,214,000USD | -14,827,000USD | -15,711,000USD | -17,701,000USD | -17,875,000USD |
| Short Term Debt | — | 536,000USD | 574,000USD | 608,000USD | 591,000USD | 697,000USD | 789,000USD | 852,000USD |
| Short Long Term Debt | — | 305,000USD | 416,000USD | 252,000USD | 213,000USD | 305,000USD | 380,000USD | 461,000USD |
| Short Long Term Debt Total | — | 1,792,000USD | 1,491,000USD | 1,712,000USD | 1,808,000USD | 2,026,000USD | 2,259,000USD | 2,485,000USD |
| Long Term Debt | — | 846,000USD | 876,000USD | 907,000USD | 943,000USD | 978,000USD | 1,032,000USD | 1,080,000USD |
| Accounts Payable | — | 8,348,000USD | 5,812,000USD | 5,373,000USD | 4,636,000USD | 6,749,000USD | 6,596,000USD | 7,803,000USD |
| Property Plant Equipment Gross | — | 4,500,000USD | 6,221,000USD | 6,588,000USD | 6,871,000USD | 7,401,000USD | 7,484,000USD | 7,604,000USD |
| Accumulated Other Comprehensive Income | — | -95,000USD | -118,000USD | -117,000USD | -135,000USD | -77,000USD | -66,000USD | -93,000USD |
| Common Stock Shares Outstanding | — | 2,599,200shares | 2,599,200shares | 2,599,200shares | 2,596,300shares | 2,596,300shares | 2,596,305shares | 1,898,200shares |
| Non Current Assets Total | — | 3,661,999USD | 3,309,000USD | 3,804,000USD | 4,178,000USD | 4,729,000USD | 4,998,000USD | 5,308,000USD |
| Non Current Liabilities Total | — | 1,256,000USD | 917,000USD | 1,104,000USD | 1,217,000USD | 1,329,000USD | 1,470,000USD | 1,633,000USD |
| Non Currrent Assets Other | — | 589,999USD | 37,000USD | 79,000USD | 87,000USD | 94,000USD | 94,000USD | 94,000USD |
| Net Working Capital | — | 14,168,000USD | 15,030,000USD | 18,846,000USD | 20,647,000USD | 22,051,000USD | 23,270,000USD | 26,118,000USD |
| Unclassified Equity | — | 77,744,000USD | 77,483,000USD | 75,810,000USD | 75,705,000USD | 75,701,000USD | 75,694,000USD | 68,485,000USD |
| Intangible Assets | — | — | 422,000USD | 448,000USD | 473,000USD | 498,000USD | 524,000USD | 555,000USD |
| Good Will | — | — | 156,000USD | 156,000USD | 156,000USD | 156,000USD | 156,000USD | 156,000USD |
| Current Deferred Revenue | — | — | 193,000USD | 243,000USD | 303,000USD | 139,000USD | 89,000USD | 104,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 27,465,000USD | 36,478,000USD | 64,469,000USD | 28,644,000USD | 20,565,325USD | 4,665,014USD | 3,390,221USD | 2,435,002USD |
| Intangible Assets | 422,000USD | 524,000USD | 14,423,000USD | 50,000USD | 75,000USD | 100,000USD | 125,000USD | 200,000USD |
| Other Current Assets | 463,000USD | 404,000USD | 640,000USD | 46,000USD | 637,025USD | 29,696USD | 115,382USD | 45,639USD |
| Total Liab | 10,043,000USD | 9,680,000USD | 16,382,000USD | 2,868,000USD | 3,034,506USD | 4,099,825USD | 2,750,512USD | 1,056,287USD |
| Total Stockholder Equity | 17,308,000USD | 26,684,000USD | 32,184,000USD | 25,776,000USD | 17,530,819USD | 565,189USD | 639,709USD | 1,378,715USD |
| Other Current Liab | 2,535,000USD | 682,000USD | 1,052,000USD | 463,000USD | 1,822,907USD | 519,584USD | 426,441USD | 292,572USD |
| Common Stock | 3,000USD | 3,000USD | 2,000USD | 1,000USD | 705USD | 408USD | 12USD | 93USD |
| Capital Stock | 3,000USD | 3,000USD | 2,000USD | 1,440USD | 705USD | 408USD | 12USD | 1,777USD |
| Retained Earnings | -60,063,000USD | -48,950,000USD | -34,925,000USD | -31,147,000USD | -21,986,215USD | -13,878,553USD | -11,115,178USD | -9,735,421USD |
| Good Will | 156,000USD | 156,000USD | 731,000USD | -49,951,000USD | — | — | -124,875,000USD | — |
| Cash | 13,709,000USD | 19,960,000USD | 26,307,000USD | 18,891,000USD | 17,267,978USD | 728,762USD | 75,362USD | 142,888USD |
| Cash And Short Term Investments | 13,709,000USD | 19,960,000USD | 26,307,000USD | 18,891,000USD | 17,267,978USD | 728,762USD | 75,362USD | 142,888USD |
| Total Current Assets | 24,156,000USD | 31,480,000USD | 43,638,000USD | 21,183,000USD | 19,374,956USD | 1,372,467USD | 877,446USD | 715,157USD |
| Total Current Liabilities | 9,126,000USD | 8,210,000USD | 14,237,000USD | 2,062,000USD | 2,780,749USD | 1,516,525USD | 1,444,468USD | 1,056,287USD |
| Current Deferred Revenue | 193,000USD | 89,000USD | 42,000USD | 36,000USD | 96,498USD | 36,704USD | 41,207USD | 56,800USD |
| Net Debt | -12,218,000USD | -17,701,000USD | -23,300,000USD | -17,816,000USD | -16,902,759USD | 17,565USD | 321,493USD | -103,861USD |
| Short Term Debt | 574,000USD | 789,000USD | 862,000USD | 269,000USD | 111,462USD | 193,804USD | 53,720USD | 39,027USD |
| Short Long Term Debt | 416,000USD | 380,000USD | 312,000USD | 60,490USD | 56,391USD | 163,679USD | 24,483USD | — |
| Short Long Term Debt Total | 1,491,000USD | 2,259,000USD | 3,007,000USD | 1,075,000USD | 365,219USD | 746,327USD | 396,855USD | 39,027USD |
| Long Term Debt | 876,000USD | 1,032,000USD | 1,211,000USD | 156,266USD | 253,757USD | 529,949USD | 291,515USD | — |
| Net Receivables | 6,588,000USD | 6,235,000USD | 11,556,000USD | 959,000USD | 450,258USD | 252,587USD | 320,404USD | 257,606USD |
| Inventory | 3,396,000USD | 4,881,000USD | 5,135,000USD | 1,287,000USD | 1,019,695USD | 361,422USD | 366,298USD | 269,024USD |
| Accounts Payable | 5,812,000USD | 6,596,000USD | 12,142,000USD | 1,200,000USD | 846,380USD | 747,476USD | 901,244USD | 625,157USD |
| Property Plant Equipment Net | 2,694,000USD | 4,224,000USD | 5,577,000USD | 2,101,000USD | 1,065,502USD | 1,161,770USD | 1,424,866USD | 1,519,845USD |
| Property Plant Equipment Gross | 6,221,000USD | 7,484,000USD | 8,080,000USD | 3,965,908USD | 2,568,003USD | 2,372,869USD | 2,413,236USD | — |
| Accumulated Other Comprehensive Income | -118,000USD | -66,000USD | -63,000USD | -41,000USD | 3,236USD | -42,832USD | -2,152USD | -6,172USD |
| Common Stock Shares Outstanding | 2,599,200shares | 2,061,400shares | 1,749,400shares | 962,959shares | 408,083shares | 26,791shares | 2,124shares | 1,249shares |
| Non Current Assets Total | 3,309,000USD | 4,998,000USD | 20,831,000USD | 7,461,000USD | 1,190,369USD | 3,292,547USD | 2,512,775USD | 1,719,845USD |
| Non Current Liabilities Total | 917,000USD | 1,470,000USD | 2,145,000USD | 806,000USD | 253,757USD | 2,583,300USD | 1,306,044USD | 0USD |
| Non Currrent Assets Other | 37,000USD | 94,000USD | 100,000USD | 49,000USD | 49,867USD | -1,261,770USD | -1,549,866USD | 200,000USD |
| Net Working Capital | 15,030,000USD | 23,270,000USD | 29,401,000USD | 19,123,012USD | 16,594,207USD | -144,058USD | -567,022USD | -341,130USD |
| Unclassified Equity | 77,483,000USD | 75,694,000USD | 67,168,000USD | 56,961,560USD | 39,512,388USD | 14,485,758USD | 11,757,015USD | 11,118,438USD |
| Long Term Investments | — | — | 0USD | 5,260,525USD | 0USD | — | — | — |
| Other Assets | — | — | — | — | 49,867USD | — | — | — |
| Net Tangible Assets | — | — | — | — | 17,455,819USD | 465,189USD | 514,709USD | 1,178,605USD |
| Unclassified Non Current Assets | — | — | — | — | — | 2,030,777USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | 2,053,351USD | 1,014,529USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,118,000USD | -5,146,000USD | -2,185,000USD | -1,789,000USD | -1,343,000USD | -3,017,000USD | -7,665,000USD | -5,311,000USD |
| Depreciation | 90,000USD | -172,000USD | 251,000USD | 263,000USD | 295,000USD | 294,000USD | 474,000USD | 1,018,999USD |
| Stock Based Compensation | 261,000USD | 424,000USD | 205,000USD | 4,000USD | 7,000USD | -5,000USD | 479,000USD | 546,000USD |
| Other Non Cash Items | 313,000USD | 408,000USD | 52,000USD | 167,000USD | -93,000USD | 302,000USD | 3,636,000USD | 1,326,000USD |
| Change To Account Receivables | -1,288,000USD | 429,000USD | -1,735,000USD | 3,170,000USD | -1,517,000USD | 2,175,000USD | 3,597,000USD | 3,697,000USD |
| Change To Inventory | -573,000USD | 2,220,000USD | -402,000USD | -740,000USD | 386,000USD | 1,102,000USD | -1,661,000USD | 1,046,000USD |
| Change In Working Capital | -1,868,000USD | 4,184,000USD | -1,051,000USD | 314,000USD | -925,000USD | 1,950,000USD | -1,533,000USD | 4,726,000USD |
| Total Cash From Operating Activities | -2,583,000USD | -302,000USD | -2,728,000USD | -1,041,000USD | -2,059,000USD | -476,000USD | -4,609,000USD | 2,306,000USD |
| Capital Expenditures | 0USD | -37,000USD | 0USD | -12,000USD | -22,000USD | -32,000USD | -97,000USD | -60,000USD |
| Free Cash Flow | -2,583,000USD | -339,000USD | -2,728,000USD | -1,053,000USD | -2,081,000USD | -444,000USD | -4,706,000USD | 2,246,000USD |
| Net Borrowings | -141,000USD | 133,000USD | 3,000USD | -127,000USD | -134,000USD | 22,000USD | 84,000USD | — |
| Total Cash From Financing Activities | -141,000USD | 133,000USD | -97,000USD | -127,000USD | -134,000USD | 22,000USD | 84,000USD | -33,000USD |
| Change In Cash | -2,701,000USD | -217,000USD | -2,709,000USD | -1,102,000USD | -2,223,000USD | -400,000USD | -4,517,000USD | 1,351,000USD |
| Begin Period Cash Flow | 13,709,000USD | 13,926,000USD | 16,635,000USD | 17,737,000USD | 19,960,000USD | 20,360,000USD | 24,877,000USD | 23,526,000USD |
| End Period Cash Flow | 11,008,000USD | 13,709,000USD | 13,926,000USD | 16,635,000USD | 17,737,000USD | 19,960,000USD | 20,360,000USD | 24,877,000USD |
| Total Cashflows From Investing Activities | — | -37,000USD | 102,000USD | 120,000USD | -22,000USD | 28,000USD | — | -918,000USD |
| Sale Purchase Of Stock | — | 100,000USD | -100,000USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | 102,000USD | — | 132,000USD | — | -4,000USD | 97,000USD | — |
| Other Cashflows From Financing Activities | — | -225,000USD | — | — | -129,000USD | — | — | 62,000USD |
| Investments | — | — | 102,000USD | 120,000USD | -22,000USD | 28,000USD | 0USD | -918,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,463,000USD | -23,125,000USD | -12,407,000USD | -9,161,000USD | -8,107,662USD | -2,763,375USD | -1,379,756USD | -1,194,706USD |
| Depreciation | 637,000USD | 2,822,000USD | 2,527,000USD | 596,000USD | 350,065USD | 322,999USD | 284,880USD | 288,864USD |
| Stock Based Compensation | 640,000USD | 1,632,000USD | 5,376,000USD | 2,974,000USD | 3,758,424USD | 904,900USD | 0USD | 219,518USD |
| Other Non Cash Items | 534,000USD | 13,918,000USD | 3,946,000USD | 1,782,000USD | 1,404,533USD | 687,293USD | 355,445USD | 110USD |
| Change To Account Receivables | 347,000USD | 5,267,000USD | -3,661,000USD | -16,000USD | -689,088USD | 67,817USD | -73,827USD | 123,970USD |
| Change To Inventory | 1,464,000USD | 12,000USD | -2,217,000USD | -267,000USD | -658,274USD | 4,876USD | -97,274USD | 63,872USD |
| Change In Working Capital | 2,522,000USD | -711,000USD | -3,038,000USD | 207,000USD | -1,497,450USD | 11,203USD | 80,228USD | 96,029USD |
| Total Cash From Operating Activities | -6,130,000USD | -5,464,000USD | -3,596,000USD | -3,602,000USD | -4,092,090USD | -836,980USD | -659,203USD | -590,185USD |
| Capital Expenditures | -71,000USD | -189,000USD | -647,000USD | -716,000USD | -229,307USD | -34,903USD | -70,194USD | -30,331USD |
| Free Cash Flow | -6,201,000USD | -5,653,000USD | -4,243,000USD | -4,318,000USD | -4,321,397USD | -871,883USD | -729,397USD | -620,516USD |
| Total Cashflows From Investing Activities | 163,000USD | -953,000USD | 5,199,000USD | -7,716,000USD | -229,307USD | -34,903USD | -70,194USD | -30,331USD |
| Net Borrowings | -125,000USD | -135,000USD | -324,000USD | -67,000USD | 133,205USD | 1,565,963USD | 659,327USD | 32,029USD |
| Total Cash From Financing Activities | -225,000USD | 72,000USD | 5,860,000USD | 13,011,000USD | 20,817,317USD | 1,565,963USD | 659,327USD | 532,030USD |
| Sale Purchase Of Stock | -100,000USD | 0USD | -7,145,000USD | — | — | — | — | — |
| Change In Cash | -6,251,000USD | -6,347,000USD | 7,416,000USD | 1,623,000USD | 16,539,216USD | 653,400USD | -67,526USD | -90,438USD |
| Begin Period Cash Flow | 19,960,000USD | 26,307,000USD | 18,891,000USD | 17,268,000USD | 728,762USD | 75,362USD | 142,888USD | 233,326USD |
| End Period Cash Flow | 13,709,000USD | 19,960,000USD | 26,307,000USD | 18,891,000USD | 17,267,978USD | 728,762USD | 75,362USD | 142,888USD |
| Other Cashflows From Investing Activities | 234,000USD | 94,000USD | -1,506,000USD | 7,000,000,000USD | — | — | — | — |
| Other Cashflows From Financing Activities | -225,000USD | 207,000USD | 184,000USD | -754,000USD | 6,555,376USD | 50,989USD | 12,044USD | 532,030USD |
| Investments | — | -953,000USD | 5,143,795USD | -7,715,592USD | -229,307USD | -34,903USD | -70,194USD | -30,331USD |
| Issuance Of Capital Stock | — | 0USD | 14,226,900USD | 13,831,938USD | 14,061,984USD | 0USD | 0USD | 500,000USD |
| Unclassified Investing Cash Flow | — | — | 2,208,205USD | -6,999,284,408USD | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 13,145,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | — | 10,802USD | -116,119USD | 311,257USD | -177,507USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | Africa | 40,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 411,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 1,514,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 1,214,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Geography | South America | 20,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Product | Ecommerce Revenue | 3,199,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Product | Pharmacy Contract Revenue | 1,872,000 | USD | 0001437749-26-017156 |
| Q1 2026Quarterly · 2026-03-31 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 4,784,000 | USD | 0001437749-26-017156 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Africa | 188,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Asia Pacific | 568,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Europe | 2,018,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | North America | 992,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | South America | 14,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Africa | 462,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 1,968,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 7,451,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 4,683,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Geography | South America | 44,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Product | Ecommerce Revenue | 14,608,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 35,704,000 | USD | 0001437749-26-010668 |
| FY 2025Yearly · 2025-12-31 | Product | Pharmacy340b Contract | 4,010,000 | USD | 0001437749-26-010668 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Africa | 42,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia Pacific | 411,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 1,867,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 1,374,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Geography | South America | 8,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Product | Ecommerce Revenue | 3,702,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 9,495,000 | USD | 0001437749-25-034525 |
| Q3 2025Quarterly · 2025-09-30 | Product | Pharmacy340b Contract | 555,000 | USD | 0001437749-25-034525 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Africa | 188,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia Pacific | 641,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 1,993,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Geography | North America | 1,284,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Geography | South America | 14,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Product | Ecommerce Revenue | 4,120,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 8,173,000 | USD | 0001437749-25-026604 |
| Q2 2025Quarterly · 2025-06-30 | Product | Pharmacy340b Contract | 947,000 | USD | 0001437749-25-026604 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Africa | 44,000 | USD | 0001437749-26-017156 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 348,000 | USD | 0001437749-26-017156 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 1,573,000 | USD | 0001437749-26-017156 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 1,033,000 | USD | 0001437749-26-017156 |
| Q1 2025Quarterly · 2025-03-31 | Geography | South America | 8,000 | USD | 0001437749-26-017156 |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 14,525,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 1,708,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Africa | 683,000 | USD | 0001437749-26-010668 |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 1,720,000 | USD | 0001437749-26-010668 |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 6,812,000 | USD | 0001437749-26-010668 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 4,529,000 | USD | 0001437749-26-010668 |
| FY 2024Yearly · 2024-12-31 | Geography | South America | 47,000 | USD | 0001437749-26-010668 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 55,540,000 | USD | 0001437749-26-010668 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 10,542,000 | USD | 0001437749-26-010668 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Africa | 28,000 | USD | 0001437749-25-034525 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia Pacific | 429,000 | USD | 0001437749-25-034525 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 2,018,000 | USD | 0001437749-25-034525 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 1,349,000 | USD | 0001437749-25-034525 |
| Q3 2024Quarterly · 2024-09-30 | Geography | South America | 10,000 | USD | 0001437749-25-034525 |
| Q3 2024Quarterly · 2024-09-30 | Product | Ecommerce Revenue | 3,834,000 | USD | 0001437749-24-034987 |
| Q3 2024Quarterly · 2024-09-30 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 9,076,000 | USD | 0001437749-24-034987 |
| Q3 2024Quarterly · 2024-09-30 | Product | Pharmacy340b Contract | 2,457,000 | USD | 0001437749-24-034987 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Ecommerce | 3,834,000 | USD | 0001437749-24-034987 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Ecommerce Revenue — Healthcare Operations | 11,533,000 | USD | 0001437749-24-034987 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Africa | 25,000 | USD | 0001437749-25-026604 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Asia Pacific | 390,000 | USD | 0001437749-25-026604 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Europe | 1,797,000 | USD | 0001437749-25-026604 |
| Q2 2024Quarterly · 2024-06-30 | Geography | North America | 1,293,000 | USD | 0001437749-25-026604 |
| Q2 2024Quarterly · 2024-06-30 | Geography | South America | 7,000 | USD | 0001437749-25-026604 |
| Q2 2024Quarterly · 2024-06-30 | Product | Ecommerce Revenue | 3,512,000 | USD | 0001437749-24-026477 |
| Q2 2024Quarterly · 2024-06-30 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 10,521,000 | USD | 0001437749-24-026477 |
| Q2 2024Quarterly · 2024-06-30 | Product | Pharmacy340b Contract | 2,956,000 | USD | 0001437749-24-026477 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Ecommerce | 3,512,000 | USD | 0001437749-24-026477 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Ecommerce Revenue — Healthcare Operations | 13,477,000 | USD | 0001437749-24-026477 |
| Q1 2024Quarterly · 2024-03-31 | Product | Ecommerce Revenue | 2,865,000 | USD | 0001437749-24-017030 |
| Q1 2024Quarterly · 2024-03-31 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 11,324,000 | USD | 0001437749-24-017030 |
| Q1 2024Quarterly · 2024-03-31 | Product | Pharmacy340b Contract | 3,304,000 | USD | 0001437749-24-017030 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Ecommerce | 2,865,000 | USD | 0001437749-24-017030 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Ecommerce Revenue — Healthcare Operations | 14,628,000 | USD | 0001437749-24-017030 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 32,389,000 | USD | 0001437749-25-008787 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 5,367,000 | USD | 0001437749-25-008787 |
| Q3 2023Quarterly · 2023-09-30 | Product | Ecommerce Revenue | 2,931,000 | USD | 0001437749-24-034987 |
| Q3 2023Quarterly · 2023-09-30 | Product | Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 9,888,000 | USD | 0001437749-24-034987 |
| Q3 2023Quarterly · 2023-09-30 | Product | Pharmacy340b Contract | 2,471,000 | USD | 0001437749-24-034987 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Ecommerce | 2,930,721 | USD | 0001437749-23-031707 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Healthcare Operations | 12,359,450 | USD | 0001437749-23-031707 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Africa | 39,779 | USD | 0001437749-23-023378 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Asia Pacific | 335,290 | USD | 0001437749-23-023378 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Europe | 1,704,321 | USD | 0001437749-23-023378 |
| Q2 2023Quarterly · 2023-06-30 | Geography | North America | 869,682 | USD | 0001437749-23-023378 |
| Q2 2023Quarterly · 2023-06-30 | Geography | South America | 8,290 | USD | 0001437749-23-023378 |
| FY 2022Yearly · 2022-12-31 | Geography | Africa | 136,000 | USD | 0001437749-24-011806 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 760,000 | USD | 0001437749-24-011806 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 8,617,000 | USD | 0001437749-24-011806 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 2,152,000 | USD | 0001437749-24-011806 |
| FY 2022Yearly · 2022-12-31 | Geography | South America | 45,000 | USD | 0001437749-24-011806 |
| FY 2022Yearly · 2022-12-31 | Product | Ecommerce Revenue — Product | 11,710,000 | USD | 0001437749-24-011806 |
| FY 2022Yearly · 2022-12-31 | Product | Ecommerce Revenue — Services | 0 | USD | 0001437749-24-011806 |
| FY 2021Yearly · 2021-12-31 | Geography | Africa | 84,377 | USD | 0001493152-23-010400 |
| FY 2021Yearly · 2021-12-31 | Geography | Asia Pacific | 695,770 | USD | 0001493152-23-010400 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 5,146,336 | USD | 0001493152-23-010400 |
| FY 2021Yearly · 2021-12-31 | Geography | North America | 1,776,288 | USD | 0001493152-23-010400 |
| FY 2021Yearly · 2021-12-31 | Geography | South America | 37,139 | USD | 0001493152-23-010400 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.